r/bioinformatics • • 22h ago

technical question does anyone know of any protein targets on ChEMBL with a lot of unique ligands to work with?

4 Upvotes

I’m trying to do a machine learning project, and I’m tired of spending 30-50 minutes to clean a dataset just for the rows to go from 100,000 to 100 🙂.

It’s honestly gambling my time and motivation.


r/bioinformatics • • 1d ago

technical question Feels like I'm going crazy. Secondary analysis of already published work troubles

10 Upvotes

Sorry for the kinda long post

I'm a grad student in biotech working specifically with miRNAs of Mesenchymal Stem Cells. My previous training and work is purely wet-lab focused but I've been wanting to dive into bioinfo to better analyze my work when I do miRNA-seq of my own as well as be able to better read the actual data of published work instead of what is highlighted in the articles by their authors.

I first made sure to follow the user guide of miRge 3.0 (as well as do some studying on the topic and the work environments, such as wsl and R) and was able to pretty reliably re-create the results from their sample data, with some small differences most probably attributable to newer editions of software used.

I then thought I'd take a stab at messing around with deposited SRA accessions from GEO, which made sense to me as I have a reference paper already ready which I can compare my results directly to as a check of my own methods. Honestly though? Going through the data in my field has been so confusing and I genuinely feel lost. First, it feels like the concept of best standards for analysis and reporting results is viewed as a suggestion by the majority of authors. I've seen things like reporting anything with raw p-values under 0.05 as significant, which I can only assume was done because running any p-value adjustment leads to 0 significant differentially expressed miRNAs. The documentation of the methodology used or code used for analysis is also almost non-existant and is very vague, making precise recreation of results hard. One of the most egregious examples was in a paper reporting a certain miRNA as their top candidate and discussing it in length, while when I accessed their public GEO records and generated the count tables I literally got ZERO counts in all samples for said miRNA.

Since I am very new to this, I am not quite sure if the problem is me or the data I'm trying to analyze, and I would dearly appreciate any advice from you experienced folk here.


r/bioinformatics • • 2d ago

discussion what's the coolest example of independent bfx/bioML people doing real work? on a small scale, just themselves or at most a handful of people working together on something and getting results.

2 Upvotes

could be anything related to bfx. seriously it's 2026... twitter died years ago now so I lost all science community honestly ( that was a psyop)

so anything come to mind?


r/bioinformatics • • 3d ago

academic I made a study group for Bioinformatics students

0 Upvotes

So i made a group for Btech Bioinformatics student on yeolpumta study app So we can study together and Grow

We study daily and also work on skills also who wants to Join group

Link 👇

https://link.yeolpumta.com/P3R5cGU9Z3JvdXBJbnZpdGUmaWQ9Nzg5MDYzOA==

And link in pinned comment also


r/bioinformatics • • 3d ago

article I’ve rewritten Learn Genomics, a guide to teach students and software engineers genomics

229 Upvotes

Hi all,

I'm a software engineer working in genomics at St. Jude Children's Research Hospital. I created Learn Genomics (https://learngenomics.dev), an open-source guide to teach students and software engineers the basics needed to work in genomics.

Over the last month or so, I've roughly doubled the amount content and rewritten most of what was already there, including:

- A whole new section on cancer biology,
- More comprehensive coverage of the commonly used file formats,
- A more modern worked example of an analysis, and
- Many more updated figures

You can find the source at https://github.com/stjude/learngenomics.dev.

If you have anyone who would benefit from reading it, I’d be grateful if you could share with them. Additionally, I'm hoping folks in the know can give feedback on any parts that are ambiguous/outright incorrect so we can correct those.

Enjoy!


r/bioinformatics • • 3d ago

technical question Genome annotation of short read genome assemblies - help!

2 Upvotes

I have been trying to reannotate some insect genomes that on paper look decent - one that I'm currently focused on has 700 contigs, n50 of 7mb, 97% busco completeness. However any annotation software/pipeline I try fails miserably. It was originally annotated several years ago using the ensembl pipeline with the proteome busco C of 75% and clearly there are many issues with the annotation. To improve it I've tried several tools including ab initio and evidence based approaches (with proteins and rna-seq data) - ANNEVO, BRAKER4, Tiberius, a few others, and for all of them BUSCO C score ranges between 30%-50%. For comparison I'm using a chromosome-level assembly of a related insect, and most of these tools easily reach reference annotation quality.

I've been at it for months now and really wanted to use these genomes for comparative genomics - at least to compare certain gene families. This is my first time annotating a genome and I'm a bit stumped, so are my supervisors and other people in the field. At this point any ideas/suggestions are welcome


r/bioinformatics • • 4d ago

technical question Should I downsample CUT&RUN datasets from different laboratories before comparing peak overlaps?

1 Upvotes

Hello! I have two CUT&RUN datasets targeting two different proteins, generated in different laboratories but using the same cell type.

Both FASTQ datasets were processed using the same bioinformatics pipeline and parameters. However, they have different sequencing depths, and I only have one sample per protein, without IgG controls or spikeins.

My goal is to identify overlapping genomic binding regions between these two proteins.

Should I downsample the deeper dataset to match the sequencing depth of the shallower one before peak calling and calculating peak overlaps? Or should go ahead with the anamysis without any normalization ?

Also, is any batch-effect correction necessary or appropriate when the two proteins were profiled in different laboratories?

Thank you sm


r/bioinformatics • • 4d ago

technical question How do you tell if ONT long-read RNA-seq data are good enough for gene and isoform quantification?

7 Upvotes

I’m working on a small ONT long-read RNA-seq pilot using EPI2ME’s wf-transcriptomes workflow (Bambu). We have three samples from different conditions and no biological replicates. The goal is to see whether the workflow produces data suitable for a larger, replicated study.

Beyond Q scores, alignment rates, and read length distributions, what would give you confidence in the data for these two applications?

  • Gene-level expression: What do you look for in gene detection and normalized expression? Are there descriptive comparisons that help you assess whether the data capture expected biology when you only have one sample per condition?

  • Isoform detection and quantification: How do you use full splice matches, full-length read support, and recovery across transcript lengths to decide whether isoform abundance estimates are interpretable?

  • Splice junction QC: If you see small shifts in splice-site positions or noncanonical junctions, how do you tell whether they affect gene-level counts or mainly affect isoform calls?

If you’ve run a similar pilot, what gave you enough confidence to scale up, and which metrics did you keep using on later runs?


r/bioinformatics • • 5d ago

academic Thoughts on current single-cell foundation models? Is anyone actually using them in industry?

12 Upvotes

I’m a grad researcher working on single-cell models, mostly exploring different ways of training them to make them better. The more time I spend in this area, the more I have a feeling it’s pretty hyped (eg. the published benchmarks are sometimes totally PR) it's hard to tell whether on some tasks cell foundational model is beating the baseline?

Two things I keep running into:

  1. Just reimplementing these models is already hard, never mind fine-tuning them. Most people I talk to who work on this have struggled to even get inference running on the existing open-source models. The code of these open sourced models are really poorly maintained...

  2. I’m not sure how they actually fit into a real drug discovery pipeline. Yes, they can do basic cell annotation and maybe target prioritization, but I don’t think that’s a game changer compared to traditional methods. I know a few people in biotech shared similar concerns and I’m still not clear on what the models are being used for day to day or to what extent?

So for anyone in industry, or anyone who’s trained or deployed these: what are you actually using them for? Has anything been genuinely useful beyond annotation? Or is it mostly still exploratory?

Would really appreciate honest takes, including “we tried it and it didn’t help.”


r/bioinformatics • • 5d ago

technical question How are people linking plasmids to their bacterial hosts in metagenomics?

6 Upvotes

One thing I keep coming across in metagenomics is how hard it can be to tell which bacteria actually carry a plasmid. Assembly gives you the sequences, but linking them back to the right host seems less clear. I've seen Hi-C and single cell methods mentioned as possible approaches. Curious which methods people trust for this, especially with mixed environmental samples.


r/bioinformatics • • 6d ago

technical question Best approach to analyse single cell patient data of multiple subtypes and unequal sample distribution?

6 Upvotes

Hi everyone!

I was recently handed a large amount of single cell AML patient sample data and the end goal is to come up with therapeutic vulnerabilities as well as molecular candidates to segregate the tumor cells from immune cells.

The data comprises of samples of AML patients from 5 different genetic backgrounds (by WHO classification). Sample distribution is uneven as well with patient sample numbers ranging from 1 t0 7. We have two healthy bone marrow samples as control, which automatically translates to vast differences in cell numbers between control vs condition samples.

My initial idea was to analyse one subtype at a time, downsample the integrated rds of condition or control (depending on which one has the lower number of cells), integrate control and condition, look for any patient specific cluster and take it from there. One subtype in, I quickly realized the complexity and areas of bias introduction I might be dealing with. So I am having doubts on my method.

I would like to hear from people who handle and have handled such analyses. What would be the best way to go about it? Link to papers and resources where I can read up on it would be highly appreciated!


r/bioinformatics • • 6d ago

technical question Only 3 out of 20 candidate enhancers validated. What would you do with the remaining 17?

12 Upvotes

We have scATAC-seq data from FACS-sorted cells and identified interesting candidate cis-regulatory elements in our target cell clusters. We selected around 20 candidates and tested them in vivo, but only 3 came out positive.

I'm fine with that result. The other regions could be accessible for all sorts of reasons and don't necessarily have enhancer activity in our assay.

PI, however, is puzzled by the negative results and wants to check whether these regions overlap with repressive or poised histone marks using around 15 different ChIP-seq datasets. These datasets come from different experiments, developmental stages and sometimes even different tissues/organs.

I'm wondering what would be the best way to approach this. Should I simply inspect the bigWig tracks visually and check whether there's enrichment over our CCREs in both ATAC and ChIP-seq?

I honestly doubt this would explain much. I might be naiive, but I don't think reviewers would question the fact that perfect shining peaks in ATAC can sometimes turn out negative in vivo.

Has anyone dealt with something similar?


r/bioinformatics • • 6d ago

discussion Understanding access privacy, confidentiality and disclosure control in bioinformatics

Thumbnail people.uwe.ac.uk
2 Upvotes

Dear all,

I'm an academic based in the UK working on a large project which supports data services and platforms (such as UK Biobank, Office of National Statistics, UK Data Archive and many more), much of our work has also been adopted globally.  All tools and documentation we produce are free to access and in the public domain (no profit here)! They are openly available to download https://github.com/AI-SDC and all research papers/ documentation is available here https://zenodo.org/communities/dare_uk/

I'm interested in getting thoughts/ views/ feedback from people who have used (or tried to use) secure or controlled-access datasets to better understand their experiences and the practical challenges they encounter. Although we are actively working with a large range of Trusted Research Environments but we are particulary lacking insights into experiences of bioinformatics, genomics, and biostatistics researchers (TREs are popular in social sciences and we're still unpicking disclosure control problems for bio and genomics).

I'm hoping to gain a better understanding of peoples opinion

  • Working with secure data platforms: What works well, and what can be frustrating or unnecessarily complicated?

  • Statistical disclosure control (SDC) and output checking: Have you encountered challenges when preparing results for release, or experienced delays or difficulties with output checking requirements? Do you feel SDC is different for genomic/ bio data?

  • Guidance and support: Are the rules and processes clear? Is there anything you wish you'd known before starting- as many of us (myself included) never had formal statistical disclosure control training before working in a secure server...

  • Improving researcher workflows: What tools, training or changes would make your research easier?

I'm genuinely interested in hearing about positive experiences, frustrations, criticisms and suggestions. There's no expectation that researchers should agree with existing approaches or think that everything needs to be more restrictive!

This is an informal discussion, not a formal research survey or interview. I won't be collecting, quoting or analysing comments from this thread as research data. I'm simply hoping to learn more about the experiences and challenges researchers are encountering and to have a constructive conversation.

I've checked with the moderators before posting, and they've kindly given permission.

Please don't share any confidential data, restricted research outputs or information that might breach your data access agreements.

Thanks so much for reading, and any thoughts, experiences or questions are welcome!


r/bioinformatics • • 6d ago

academic Feedback on my first in silico project (DISC1 knockout prediction)

0 Upvotes

Hi all, I’m a bioinformatics learner. I built a small in silico project on DISC1: STRING network analysis, GO enrichment, CRISPR guide design, and a comparison of predicted vs actual mouse knockout phenotypes. The network recovered the neurological signal but only 2 of 8 impacted systems. What is one thing I should fix or learn next? Happy to share the repo with anyone who wants to look. Thank you!


r/bioinformatics • • 6d ago

other Any recommendations for a modern bioinformatics textbook with an evolutionary focus?

25 Upvotes

Hi all,

Any recommendations for a modern textbook that teaches the fundamentals of bioinformatics from an evolutionary biology perspective? I’m looking for something that explains how core algorithms work and how to use current tools/methods for sequence database searches, pairwise and multiple alignment of DNA, RNA, and protein sequences, and phylogenetic inference and interpretation.

The thing is, I’m really looking for a book that uses examples from plants, animals, fungi, microbes to show how these methods can help us understand biodiversity and the history of life. Most of the books I’ve found lean toward biomedical applications or assume a computer science audience. Of course, exercises with real datasets in R or Python would be a big plus.

Thanks a lot!


r/bioinformatics • • 6d ago

academic Is there a way to make your .pdb files public?

7 Upvotes

I'm morking with proteins in B. bassiana ARSEF 2860 and some of them aren't in the AF database. Those that aren't there are just too big (biggest: 5124 aa, median: 1562 aa). These predictions need too much computational power, I just wanna know if I can make these files public once I get them so another person doesn't need to do that work., like a public repository? Or maybe there's another database that has them and I don't need to run the prediction.


r/bioinformatics • • 6d ago

discussion Wet-lab/theory biology background, now in a computational PhD, and I can’t tell if I’m learning or just handing everything to AI

109 Upvotes

I'm in my early 20s and in the second year of my computational PhD. My undergrad was a biology, wet-lab, theory-heavy focused degree, and I went straight into the PhD without a master's (which you can do that in the UK and Ireland). I finished near the top of my class, did a handful of research internships, and got 90 to 100% in most of my biostats and computational biology modules. Since then I've had fellowships and awards, I'm funded to travel to conferences, and I'm writing papers (myself, btw).

Even so, I really struggle with coding, Python especially, and with how mathematical everything has become. Looking back, those marks weren't hard to get, because in most of those modules we were handed the code and just ran each cell. Now that everything in my field is computational, I find myself getting AI to write the code because I can't keep up otherwise.

The messages I get about this are all over the place. Some PIs tell me it's fine, I have Claude, Claude can write my code. Others ask whether I can actually write it myself and say to use AI if I'm not confident. Some want no AI in their lab at all. Then there are the people on stage saying any researcher who doesn't use AI will be left behind, and the people saying AI has ruined research integrity and that you don't want to be one of those people. I honestly don't know how to balance all of it.

What prompted this post was seeing someone talk about their huge breadth in machine learning. I could say the same about theory, since I can explain how most of these methods work, but putting it into practice is where I fall apart. I know someone will say "just practise", and I am trying, but most days it feels like I either start from scratch and learn everything properly myself, or I hand the work to AI so I can keep up, and neither feels right.

I'd also love to work somewhere like Google or Amazon one day, but the online assessments keep getting harder, I assume because so many people now use AI to get through them. Coming from the bio side, my skills are never going to be a 50/50 split between biology and computing, so I don't see why I should be expected to have the same LeetCode skills as someone who did pure CS for a bio role?

I know I'm not actually a fraud, but it's how I feel most days, it's not imposter syndrome but something else entirely. Has anyone else come from a wet-lab/theory background into computational work and found a way through this? How did you build real coding skills when AI can do it faster, and how do you decide what to write yourself and what to hand off and delegate?


r/bioinformatics • • 6d ago

discussion Escaping automation

24 Upvotes

I started with a masters in quantitative systems biology at my department of biophysics. I switched to a phd in medical biochemistry where I work as a bioinformatician. Preprocessing, data exploration, ML feature selection, multi-omic integration, the whole package. The problem is all of this can be automated, especially now with Agentic AI. I even did it in langraph just for fun. I am getting really bored with this paradigm in which I am easily replaceable. The most fun I had was getting creative with the mathematical models and pipeline engineering,the rest was just manual labour. I thought about going towards the adjacent field of mechanistic pharmacology but even that could be automated with symbolic regression and genetic algorithms.

How are things in your subfield? I need to dip my toe into new waters.


r/bioinformatics • • 6d ago

technical question Do HISAT2 parameters change depending on the organism like plants, animal's and fungus

3 Upvotes

Hey guys, Im going to work on some reference-based RNA seq projects. Are there different HISAT2 aligner parameters for plants, animals, and microorganisms to get a good mapping percentage and avoid false mapping reads?


r/bioinformatics • • 7d ago

technical question Comparison of RNA-Seq and microarray data from GEO

0 Upvotes

TLDR: I am thinking of comparing data from the GEO database and by individually reanalysing the data and then aggregating across all samples, the aim is to create a reference comparison before collecting my own data as a sanity check.

Hi Everyone,

I’m planning a comparative toxicogenomics project and have found some datasets in GEO which help me solve my problem. They span RNA-seq and microarray platforms and were generated by different labs using different Daphnia magna lineages and experimental methods.

My goal is to identify DEGs that are reproducible across datasets. I’m thinking of processing each dataset independently from their respective raw data, performing differential expression analysis within each study, and then integrating the results. I’m not sure what the best practice is in this, or what would would be most appropriate. Like comparing gene-level effect sizes, using stats, or using something else entirely.

Would WGCNA (https://pmc.ncbi.nlm.nih.gov/articles/PMC2631488/) be the best method of doing this? Any advice/tips/knowledge on this would be so helpful :)


r/bioinformatics • • 7d ago

advertisement Free hackathon in New York City, Nov 13-14: build tools and visuals from millions of research findings

21 Upvotes

Hi r/bioinformatics ! I’m one of the organizers of the System Public Challenge, a free, in-person hackathon happening November 13-14 in Lower Manhattan (SoHo), and wanted to share it here.

Teams get access to the System Public Graph, an open map of millions of findings pulled from peer-reviewed research, to tackle interdisciplinary problems across climate, environment, food, and health. You’ll spend a day using it to explore real problems. Challenges come from partners like PATH, Nesta, the World Bank, and NYU’s GovLab, and cover things like malaria drug resistance, women’s health, what makes a good job, and how housing affects health.

You don’t need to be a scientist to participate, nor do you need to have a team before registering (we’ll help match solo registrants with teammates). Teams of 2-7 mix data people, designers, developers, and researchers, and there are three tracks for the challenges: Explore (analysis), Visualize (design and storytelling) and Build (tools).

Fri, Nov 13, 6-8pm: kickoff reception

Sat, Nov 14, 9am-5pm: hacking, pitches and winners

Free to attend, food provided, $7,500 in cash prizes for the top teams

No team yet? There’s a Slack channel for finding one and as noted above, we will also facilitate matchmaking

18+, registration closes Nov 13

Details and sign-up: https://system-public-challenge.devpost.com/

Happy to answer questions in the comments!


r/bioinformatics • • 8d ago

technical question Drug-response prediction with less than 10 samples, is it even possible?

6 Upvotes

Hi everyone,

I'm working on a pancreatic ductal adenocarcinoma dataset, and I'd really appreciate some methodological advice from you guys, and especially if anybody has had some experience with machine learning with high-dimensional biological data.

Before spending months developing models, I'd like to better understand what is possible with my dataset.

My dataset:

  • 9 patients, with one continuous drug-response value per patient and drug (5 differents ones)

  • Due to experimental and sequencing constraints, increasing the number of patients is not an option.

  • Approximately 100 k nuclei

The goal is theoretically "simple":

Predict drug-response AUC from gene expression and chromatin accessibility, while identifying molecular features potentially associated with drug sensitivity or resistance.

The obvious challenge is that, despite having 100,000 nuclei, I only have 9 samples with AUC labels. I understand that treating individual cells as independent labeled observations is not a way to go with the dataset and specific set-up.

Knowing this, I'd really appreciate advice on a few questions that I had after some reading...:

  1. With this low amount of sample, is meaningful drug-response prediction even feasible? What would be a objective?

  2. Are there established methods to leverage thousands of cells/instances profiles when the response labels are available only at the patient level?

  3. Would you prioritize simple regularized regression, biologically informed features, transfer learning from external datasets, multiple-instance learning (MIL), or another approach?

  4. How would you evaluate a model with such a small number of independent samples without obtaining misleading performance estimates?

  5. Are there any papers, methodological resources you'd recommend to better understand this type of problem before starting?

Thanks!


r/bioinformatics • • 8d ago

discussion I compared bwa-mem, minibwa, bwa-mem3 and Parabricks fq2bam on the same WGS sample: 20.8 h vs 4.9 h vs 3.0 h vs 3.2 h

Thumbnail
genomic.social
43 Upvotes